Concordance among the three commercially available PD-L1 assays for esophageal squamous cell carcinoma

被引：0
|
作者：
Wang, Lizhen
Guo, Jhe-Cyuan
Chuang, Chien Huai
Cao, Grace
Huang, Stacey
Liu, Jia
Guo, Tony
Wu, Tsung-Che
Li, Shuang
Lin, Jing
King, Hsi-Yu
Cai, Jun
Yang, Wenjun
Liu, Qingyuan
Allen, Simon
Wang, Yifan
Zhang, Jingyu
Hsu, Chih-Hung
机构：
[1] Roche China Holding Ltd, Shanghai, Peoples R China
[2] Natl Taiwan Univ, Canc Ctr, Taipei, Taiwan
[3] Natl Taiwan Univ, Biomed Pk Hosp, Hsinchu, Taiwan
[4] Genentech South San Francisco, San Francisco, CA USA
[5] Roche, Shanghai, Peoples R China
[6] Natl Taiwan Univ Hosp, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4058
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PROGNOSTIC UTILITY OF PD-L1 IN SQUAMOUS CELL CARCINOMA OF THE BLADDER
    Owyong, Michael
    Lotan, Yair
    Kapur, Payal
    Panwar, Vandana
    Lee, Thomas K.
    Zi, Xiaolin
    Martin, Jeremy W.
    Mosbah, Ahmed
    Abol-Enein, Hassan
    Ghoneim, Mohamed
    Youssef, Ramy F.
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1039 - E1040
  • [42] Characterization of PD-L1 Expression in Penile Squamous Cell Carcinoma
    Gellert, Lan
    Shi, Chanjuan
    Giannico, Giovanna A.
    Hameed, Omar
    LABORATORY INVESTIGATION, 2018, 98 : 342 - 343
  • [43] Clincopathologic Studies of PD-L1 Expression on Esophageal Adenocarcinoma and Squamous Cells Carcinoma
    Abu-Farsakh, Sohaib
    Lalonde, Amy
    Wu, Tongtong
    Zhou, Zhongren
    MODERN PATHOLOGY, 2017, 30 : 157A - 157A
  • [44] Clincopathologic Studies of PD-L1 Expression on Esophageal Adenocarcinoma and Squamous Cells Carcinoma
    Abu-Farsakh, Sohaib
    Lalonde, Amy
    Wu, Tongtong
    Zhou, Zhongren
    LABORATORY INVESTIGATION, 2017, 97 : 157A - 157A
  • [45] Comparing the performance of three PD-L1 antibodies for PD-L1 expression in renal cell carcinoma
    Park, S.
    Wi, Y. C.
    Shin, S.
    Jang, K.
    VIRCHOWS ARCHIV, 2019, 475 : S181 - S182
  • [46] The Regulation Effect of EGFR Signaling Pathway on PD-L1 Expression on Esophageal Squamous Cell Carcinoma Cell Lines
    Li, T.
    Wang, R.
    Lv, J.
    Huang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E682 - E682
  • [47] PD-L1 Assay Concordance in Metastatic Renal Cell Carcinoma and Metastatic Urothelial Carcinoma
    Brown, Landon C.
    Zhu, Jason
    Labriola, Matthew K.
    Wu, Yuan
    Cheris, Sachica
    Liu, Xin
    Perkinson, Kathryn
    Su, Zuowei
    McCall, Shannon
    Huang, Jiaoti
    Foo, Wen-Chi
    Gupta, Rajan T.
    Armstrong, Andrew J.
    George, Daniel J.
    Harrison, Michael R.
    Zhang, Tian
    CLINICAL GENITOURINARY CANCER, 2020, 18 (06) : 509 - 513
  • [48] PD-1 and PD-L1 staining patterns in cervical squamous cell carcinoma
    Hodeib, M.
    Lester, J.
    Laury, A.
    Cass, I.
    Rimel, B. J.
    Li, A. J.
    Karlan, B. Y.
    Walsh, C. S.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (01) : 210 - 210
  • [49] PD-L1 (22C3) expression and prognostic implications in esophageal squamous cell carcinoma
    Chi, Zhikai
    Peng, Lan
    Karamchandani, Dipti M.
    Xu, Jing
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2025, 74
  • [50] Digital versus manual pathology scoring of PD-L1 in patients with esophageal squamous cell carcinoma (ESCC).
    Duan, Chunzhe
    Guo, Jhe-Cyuan
    Liu, Jinliang
    Fu, Shijing
    Wang, Lizhen
    Chuang, Chien Huai
    Huang, Stacey
    Wu, Tsung-Che
    Zhang, Jingyu
    Hsu, Chih-Hung
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345